{
    "eid": "2-s2.0-85085028810",
    "title": "Modern biologics for rabies prophylaxis and the elimination of human cases mediated by dogs",
    "cover-date": "2020-11-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Clinical Biochemistry",
            "@code": "1308",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "Antibodies",
        "encephalitis",
        "lyssavirus",
        "mononegavirales",
        "prophylaxis",
        "rabies",
        "rhabdovirus",
        "vaccine",
        "Virus",
        "zoonosis"
    ],
    "authors": [
        "Terapong Tantawichien",
        "Charles E. Rupprecht"
    ],
    "citedby-count": 6,
    "ref-count": 130,
    "ref-list": [
        "Four thousand years of concepts relating to rabies in animals and humans, its prevention and its cure",
        "Rabies",
        "Estimating the global burden of endemic canine rabies",
        "The beginning of the end of rabies?",
        "Taxonomy of the order Mononegavirales: Update 2019",
        "Structure and function of negri bodies",
        "The importance of immune evasion in the pathogenesis of rabies virus",
        "Lyssavirus matrix protein cooperates with phosphoprotein to modulate the Jak-Stat pathway",
        "Structural and cellular biology of rhabdovirus entry",
        "Predicted 3D model of the rabies virus glycoprotein trimer",
        "Transcriptional control and mRNA capping by the GDP polyribonucleotidyltransferase domain of the rabies virus large protein",
        "Priorities in applied research to ensure programmatic success in the global elimination of canine rabies",
        "ICTV virus taxonomy profile: rhabdoviridae",
        "Rabies: a medical perspective",
        "Everything you always wanted to know about rabies virus (But were afraid to ask)",
        "Rabies: changing prophylaxis and new insights in pathophysiology",
        "Exposure history, post-exposure prophylaxis use, and clinical characteristics of human rabies cases in China, 2006-2012",
        "Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies",
        "Case reports: survival from rabies: case series from India",
        "Historical, current and expected future occurrence of rabies in enzootic regions",
        "Rabies in the Americas: 1998-2014",
        "Rabies in a dog imported from Egypt with a falsified rabies vaccination certificate\u2013Virginia, 2015",
        "Rabies virus vectors and reservoir species",
        "Natural rabies infection in a domestic fowl (Gallus domesticus): a report from India",
        "Rabies surveillance in the United States during 2018",
        "Bat lyssaviruses",
        "Rabies in rodents and lagomorphs in the United States, 1995-2010",
        "Rabies encephalitis and extra-neural manifestations in a patient bitten by a domestic cat",
        "Rabies in dogs, livestock and wildlife: a veterinary perspective",
        "Molecular inferences suggest multiple host shifts of rabies viruses from bats to mesocarnivores in Arizona during 2001-2009",
        "Right place, wrong species: a 20-year review of rabies virus cross species transmission among terrestrial mammals in the United States",
        "Large-scale phylogenomic analysis reveals the complex evolutionary history of rabies virus in multiple carnivore hosts",
        "Genetic analysis of a rabies virus host shift event reveals within-host viral dynamics in a new host",
        "The lyssavirus host-specificity conundrum-rabies virus-the exception not the rule",
        "Non-human primates as a reservoir for rabies virus in Brazil",
        "Compendium of animal rabies prevention and control, 2016",
        "Proof of concept of mass dog vaccination for the control and elimination of canine rabies",
        "Immune regulation of antibody access to neuronal tissues",
        "Rabies epidemiology: Some ecological and evolutionary perspectives",
        "Genotypic and phenotypic diversity of rabies virus variants involved in human rabies: Implications for postexposure prophylaxis",
        "The long incubation period in rabies: delayed progression of infection in muscle at the site of exposure",
        "Rabies vaccinology and immunology",
        "The role of toll-like receptors in the induction of immune responses during rabies virus infection",
        "Concepts in the pathogenesis of rabies",
        "Rabies ribonucleocapsid as an oral immunogen and immunological enhancer",
        "Human immune responses to traditional and novel rabies vaccines",
        "Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes",
        "Passive immunity in the prevention of rabies",
        "Long-term humoral and cellular immunity after vaccination with cell culture rabies vaccines in man",
        "Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine",
        "History of rabies control by vaccination",
        "The early use of Pasteur\u2019s rabies vaccine in the United States",
        "Guillain-Barre syndrome following antirabies Semple vaccine\u2013a report of six cases",
        "Immune response of suckling mouse brain (CRL) rabies vaccine and tissue culture rabies vaccine (Verorab) in pre-exposure prophylaxis in humans]",
        "Post-marketing surveillance of human rabies diploid cell vaccine (Imovax) in the vaccine adverse event reporting system (VAERS) in the United States, 1990\u20122015",
        "Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines",
        "Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis",
        "Immunogenicity, safety and tolerance of a purified duck embryo vaccine (PDEV, VAXIRAB) for rabies post-exposure prophylaxis: results of a multicentric study in India",
        "Testing a low-cost approach to giving eRIG for rabies PEP: Ethical issues",
        "Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: A comparative phase 2/3 trial",
        "Comparison of a novel human rabies monoclonal antibody to human rabies immunoglobulin for postexposure prophylaxis: a phase 2/3, randomized, single-blind, noninferiority, controlled study",
        "Current status and development of vaccines and other biologics for human rabies prevention",
        "New rabies vaccines for use in humans",
        "A history of rabies - the foundation for global canine rabies elimination",
        "WHO expert consultation on rabies. Third report",
        "Achieving scientific and regulatory success in implementing non-animal approaches to human and veterinary rabies vaccine testing: A NICEATM and IABS workshop report",
        "Clinical management and humoral immune responses to rabies post-exposure prophylaxis among three patients who received solid organs from a donor with rabies",
        "Current rabies vaccines do not confer protective immunity against divergent lyssaviruses circulating in Europe",
        "Safety review of the purified chick embryo cell rabies vaccine: Data from the vaccine adverse event reporting system (VAERS), 1997-2005",
        "Human rabies prevention\u2013United States, 2008: Recommendations of the advisory committee on immunization practices",
        "Safety, tolerability and efficacy of intradermal rabies immunization with DebioJect\u2122",
        "An outbreak of post-vaccinal rabies (Rage de laboratoire) in Fortaleza, Brazil, in 1960. Residual fixed virus as the etiological agent",
        "Paralytic rabies: an acute flaccid myelitis after inadequate post exposure prophylaxis",
        "Hydrophobia\u2019s doppelg\u00e4nger: Toward a literary history of emotions in early american rabies narratives",
        "Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection",
        "A case of immune thrombocytopenic purpura after rabies vaccination",
        "Recurrent temporary paralysis reported after human rabies post-exposure prophylaxis",
        "A case of serious adverse reaction following rabies vaccination",
        "Rabies post-exposure prophylaxis for a male with severe Henoch Sch\u00f6nlein purpura following rabies vaccination",
        "Rabies vaccine and rabies immunoglobulin in cambodia: use and obstacles to use",
        "Serum sickness after equine rabies immunoglobulin in identical male twins: two case reports",
        "When horse serum meets dog bite",
        "New method to produce equine antirabies immunoglobulin F(ab\u2019)\u2082 fragments from crude plasma in high quality and yield",
        "Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab\u2019)(2) fragments",
        "Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by \u201cpooling strategy\u201d",
        "Is the skin sensitivity test required for administering equine rabies immunoglobulin?",
        "Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies",
        "Rabies immune globulin (Human) in the prevention of rabies",
        "First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity",
        "Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans",
        "Recent advances in the development of monoclonal antibodies for rabies postexposure prophylaxis: A review of the current status of the clinical development pipeline",
        "Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases",
        "Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children",
        "An overview of the immunogenicity and effectiveness of current human rabies vaccines administered by intradermal route",
        "Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: results from a phase III clinical trial in children, adolescents and adults",
        "Evaluating new rabies post-exposure prophylaxis (PEP) regimens or vaccines",
        "Rabies post-exposure prophylaxis: A systematic review on abridged vaccination schedules and the effect of changing administration routes during a single course",
        "Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014",
        "Modelling to inform prophylaxis regimens to prevent human rabies",
        "A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): An observational cohort study",
        "Local infiltration of rabies immunoglobulins without systemic intramuscular administration: an alternative cost effective approach for passive immunization against rabies",
        "Pre-exposure rabies prophylaxis: a systematic review",
        "A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children",
        "One-week, two-visit, double-dose, intra-dermal (2(2)ID) rabies vaccination schedule for travelers: Time/dose sparing, effective but \u201coff label",
        "Evidence of rabies virus exposure among humans in the Peruvian Amazon",
        "A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial",
        "A phase II randomized study to determine the safety and immunogenicity of the novel PIKA rabies vaccine containing the PIKA adjuvant using an accelerated regimen",
        "Advances in RNA vaccines for preventive indications: A case study of a vaccine against rabies",
        "A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis",
        "Fabrication of fillable microparticles and other complex 3D microstructures",
        "Antiviral therapy for human rabies",
        "Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses",
        "Structure of a rabies virus polymerase complex from electron cryo-microscopy",
        "Targeting small molecule delivery to the brain and spinal cord via intranasal administration of rabies virus glycoprotein (RVG29)-modified PLGA nanoparticles",
        "Caring for patients with rabies in developing countries - the neglected importance of palliative care",
        "Rabies vaccine stockpile: fixing the supply chain",
        "Avoiding preventable deaths: the scourge of counterfeit rabies vaccines",
        "The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: A modelling study",
        "Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination",
        "Facilities and services of postexposure prophylaxis in anti-rabies clinics: A national assessment in India",
        "A research agenda to reinforce rabies control: A qualitative and quantitative prioritization",
        "Single-visit, 4-site intradermal (ID) rabies vaccination induces robust immune responses 5 years after 1-week, 4-site ID primary post-exposure prophylaxis in the Philippines",
        "Comparison of antibody titres between intradermal and intramuscular rabies vaccination using inactivated vaccine in cattle in Bhutan",
        "Towards rabies elimination in the Asia-Pacific region: from theory to practice",
        "Reviewing solutions of scale for canine rabies elimination in India",
        "Addressing human rights as key to the COVID-19 response"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Cumming",
            "@id": "122001689",
            "affilname": "LYSSA LLC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122001689",
            "affiliation-country": "United States"
        }
    ],
    "funding": []
}